The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women.

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

If you get out and about in Little Rock, chances are you've seen Sarah Thomas' smiling face, been cheered by her vivacity.

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...

And if you know her whole story, you may be marveling at the fact that she does all she does despite living with multiple sclerosis (MS) -- a disease that, as described on the National Multiple ...

The incidence of mental illness was higher among women with MS during both the prenatal period (incidence ratio [IR] 1.26, 95 ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis ... Some of these medications can have side effects. A doctor typically works with you to select a therapy that takes into ...

Multiple sclerosis (MS) in its end stages involves disabling and life threatening effects. Several home adaptations and palliative care are available and can improve survival, mobility ...

According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...